Markets:

Overview

News

Currencies

International

Treasuries

Quest Diagnostics (NY:DGX)

193.58 +3.19 (+1.68%)

Streaming Delayed Price Updated: 3:26 PM EDT, May 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Tesla To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday ↗

January 06, 2025

Via Benzinga

This Boeing Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗

January 06, 2025

Via Benzinga

How Is The Market Feeling About Quest Diagnostics? ↗

December 31, 2024

Via Benzinga

Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.

December 20, 2024

Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.

Via News Direct

Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services ↗

December 19, 2024

U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending.

Via Benzinga

The Analyst Landscape: 8 Takes On Quest Diagnostics ↗

December 10, 2024

Via Benzinga

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test

December 19, 2024

Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA Approval

From Mainz BioMed NV

Via GlobeNewswire

Tesla To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

December 17, 2024

Via Benzinga

This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

December 17, 2024

Via Benzinga

(DGX) - Analyzing Quest Diagnostics's Short Interest ↗

December 02, 2024

Via Benzinga

How Is The Market Feeling About Quest Diagnostics? ↗

November 11, 2024

Via Benzinga

What Analysts Are Saying About Quest Diagnostics Stock ↗

October 23, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Quest Diagnostics ↗

October 23, 2024

Via Benzinga

Guardant Health Stock Sees RS Rating Jump To 83 ↗

November 20, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83.

Via Investor's Business Daily

Navigating Earnings Season: Weather Any Storm ↗

November 16, 2024

The consequences of hurricanes like Helene and Milton are—typically—quickly shrugged aside by markets as one-off events. That is mostly correct. But not entirely so. For some companies, the revenue and...

Via Talk Markets

Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare ↗

November 09, 2024

Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization.

Via Benzinga

Topics Government

Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact ↗

October 24, 2024

LabCorp Q3 2024 EPS beats expectations at $3.50, with 7.4% revenue growth to $3.28B. Adjusted EPS guidance revised due to weather.

Via Benzinga

Topics Earnings

Earnings Preview: Quest Diagnostics ↗

October 21, 2024

Via Benzinga

Looking Into Quest Diagnostics's Recent Short Interest ↗

October 21, 2024

Via Benzinga

Decoding 7 Analyst Evaluations For Quest Diagnostics ↗

October 07, 2024

Via Benzinga

What Analysts Are Saying About Quest Diagnostics Stock ↗

August 27, 2024

Via Benzinga

This Snap Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗

October 23, 2024

Via Benzinga

Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday ↗

October 22, 2024

Via Benzinga

Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025 ↗

October 22, 2024

Quest Diagnostics reports strong Q3 with 8.5% sales growth, raises 2024 revenue guidance to $9.80 billion-$9.85 billion, citing acquisitions and new customer wins.

Via Benzinga

Uber To Rally Over 33%? Here Are 10 Top Analyst Forecasts For Monday ↗

October 07, 2024

Via Benzinga

Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain ↗

August 26, 2024

Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Quest Diagnostics are also monitoring demand and expanding testing...

Via Benzinga

Uncovering Dividend Opportunities with NYSE:DGX. ↗

July 25, 2024

Analyzing QUEST DIAGNOSTICS INC (NYSE:DGX)'s Dividend Potential.

Via Chartmill

5 Analysts Assess Quest Diagnostics: What You Need To Know ↗

July 24, 2024

Via Benzinga

8 Health Care Stocks With Whale Alerts In Today's Session ↗

August 01, 2024

Via Benzinga

LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector ↗

August 01, 2024

LabCorp reported Q2 2024 adjusted EPS of $3.94, surpassing expectations of $3.78. Sales increased by 6.2% to $3.22 billion, driven by organic revenue growth and acquisitions. LabCorp revised its 2024...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.